Cell & Gene US 2024

04 - 05 December 2024 | San Diego, CA

Connecting leaders from every stage of the value chain to drive advanced therapy development and novel biologics processing

Event Page - Hero Banner 1
Overview Cell Culture Cell & Gene Therapy Advanced Therapy Development

Explore Cell & Gene US 2024: Fast-Tracking Advanced Therapies From Discovery To Commercialization

Join the pioneers in advanced therapy at Cell & Gene US 2024 – the West Coast’s most exciting event tackling cell & gene therapy, cell culture and bioprocessing. Cell & Gene US 2024 consists of 3 programmes; 2nd Annual Cell Culture US Congress, 2nd Annual Advanced Therapy Development US Congress, and Cell & Gene Therapy Manufacturing US Congress, and it is dedicated to advancing the field of cell culture, CGT manufacturing, and regenerative medicine.

From improving process productivity and overcoming scale-up challenges, through to meeting regulatory guidelines and validating novel cell targets, it highlights novel technical and scientific updates across all phases of bioprocessing and drug development for advanced therapies. Alongside in-depth presentations, our curated programme allows for in-depth networking – fostering new partnerships that will advance your pipeline and increase access to patients in oncology, rare diseases and beyond.

Cell Culture & Bioprocessing Congress US 2024

With a need for improved efficiency in cell line development and bioprocessing, the Cell Culture & Bioprocessing Congress highlights the critical technological innovations needed to minimize cost whilst maintaining quality and safety. Discover the latest approaches impacting upstream and downstream bioprocessing, from single use technologies to process automation, modelling & digitalization. Further sessions discuss next-generation strategies to remove bottlenecks in cell line development, ensuring stability, quality and clonality.

Over 200 cell culture, bioprocessing and cell line development attendees representing global pharmaceutical organisations, leading biotechs and internationally renowned academic institutions.

Over 50 presentations and discussions focussed on the crucial issues in cell line development, bioprocessing technologies and cell culture optimization.

Agenda at a Glance


Day One, Track 1: Cell Line Engineering Ensuring Stability, Quality & Clonality

Day One, Track 2: Downstream Bioprocessing: Novel Technologies & Continuous Processing

Day Two, Track 1: Cell Lines For Therapeutic Development

Day Two, Track 2: Upstream Bioprocessing: Optimization & Quality Control

Cell & Gene Therapy Manufacturing Congress US

As companies look to progress their cell & gene therapies to market, there is a need to overcome critical challenges around the complexity and cost of manufacturing. Deep-dive into the most innovative technologies, tools and ideas that will enable the scalable manufacture of these products, ensuring that larger patient populations can benefit from novel treatments. Discussion centres around scalability, cost-effectiveness, streamlined logistics, supply chain inefficiencies and digitization.

  • Over 200 cell & gene therapy attendees representing global pharmaceutical organisations, leading biotechs and internationally renowned academic institutions
  • Over 30 presentations and discussions unpacking the process optimizations needed to produce ATMPs at a larger, more accessible scale

Agenda at a Glance


Day One, Track 3: Cell Therapy Manufacturing At Scale

Day Two, Track 2: Manufacturing Viral & Non-Vector Based Gene Therapies

Day Two, Track 3: Supply Chain & Logistics

Advanced Therapy Development Congress US

With collaboration & knowledge-sharing in the regulation, commercialization and development of advanced therapies more critical than ever, hear from cell & gene therapy leaders targeting increasingly difficult disease areas. From novel therapeutic approaches in every stage of the drug pipeline, through to the considerations of developing scalable, optimized, commercial products, it connects experts from every stage of the value chain to develop partnerships that will ensure innovative products reach the patients that desperately need them.

  • Over 200 advanced therapy attendees representing global pharmaceutical organisations, leading biotechs and internationally renowned academic institutions.
  • Over 30 presentations and discussions focussed on the key strategies delivering advanced therapies into the clinic, from developing innovative targets to establishing clear regulatory guidelines

Agenda at a Glance


Day One, Track 1:  Innovative Target Discovery & Design

Day One, Track 2: Ensuring Successful Clinical Trials & Operations

Day Two, Track 1: Preclinical & Translational Strategies

What to Expect

330

leading pharma, biotech, & academic delegates

30
hours of presentations, discussions & interactive content
11
hours of networking breaks, including speed networking & refreshments
44
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 90 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Cell & Gene US 2024: 04 - 05 December 2024, San Diego, CA, USA

Alix Eastham
Senior Manager,
Ultragenyx Gene Therapy
Amish Patel
VP of Technical Operations,
Calidi Biotherapeutics
Ashley Winslow
President & CSO,
Odylia Therapeutics
Biren Mistry
Associate Director,
Zentalis Pharmaceuticals
Chien-Chung Chen
Director, Analytical Development,
Cabaletta Bio
Dan Odenwelder
Senior Engineer III,
Biogen
Dan Shelly
VP Business Development,
Prescient Therapeutics
Gargi Roy
Associate Director,
AstraZeneca
Hemant Khanna
VP,
Iveric bio
Irina Klimanskaya
Senior Director,
Astellas Institute for Regenerative Medicine
Jack Scarcelli
Director, Head of Cell Science and Technology,
Pfizer Ltd
John Rossi
Vice President,
CARGO Theraputics Inc
Kenneth Green
Senior Director,
Vertex Pharmaceuticals
Kerry Sieger
Senior Director, Global Quality Operations,
Immatics US, Inc.
Kumkum Saxena
Vice President, Head of Research and Development,
Versatope Therapeutics
Mahwish Natalia
Associate Director,
Takeda
Morten Sogaard
Senior Vice President, Gene Therapy Research and Technical Operations,
Astellas
Nathan Moore
Director,
Takeda
Nelly Viseux
Senior Vice President,Process & AnalyticalDevelopment & ClinicalManufacturing,
2Seventybio
Nicholas Marshall
Head of Protein Sciences,
Invenra
Nitin Garg
Senior Director,
PTC Therapeutics
Shyam Subramanian
Chief Technical Officer,
Obsidian Therapeutics
Stefanie Brady
Sr. Director, Supply Chain,
REGENXBIO
Taylor Forte
Associate Director,
Biogen
William Beck
Director, Supply Chain,
CARISMA Therapeutics
Zhu Zhen Pirot
Platform CGT analytical lead,
Bayer

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

UNIVERCell: Engineering Red Blood Cells for Targeted Therapy

Scarlet Therapeutics uses genetic manipulation of red blood cells to carry a higher load of therapeutic proteins to help treat rare metabolic diseases.

Enhancing Gene Editing Efficiency: Multi-Tailed mRNA Integration in CRISPR-Cas9 Systems

A study conducted by the Broad Institute and the Massachusetts Institute of Technology (MIT) demonstrated that when multi-tailed mRNAs were integrated into a CRISPR-Cas9 system they proved to be more efficient gene editors than unmodified mRNA.

Cell Therapy for Solid Tumors: An Innovative Approach to Cancer Treatment

Cell therapy for solid tumours is an innovative cancer treatment that uses a patient's own immune cells or donor cells to fight cancer, but its effectiveness varies by tumour type and patient's immune system. Although it offers new hope, it poses risks such as cytokine release syndrome and neurotoxicity. Recent advancements have led to better targeting, combination therapies, and next-generation treatments, with future research aimed at improving safety, effectiveness, and accessibility, potentially revolutionising cancer care.

Post-Event Proceedings – Gene Therapy Development & Manufacturing 2023

Concise and insightful summaries of presentations delivered by prominent thought leaders at Gene Therapy Development & Manufacturing 2023.

Advancing Melanoma Treatment: The FDA Gives Lifileucel The Greenlight in Historic Cell & Gene Therapy Breakthrough

The Food and Drug Administration (FDA) approved lifileucel, a one-of-a-kind T-cell therapy developed by Iovance Biotherapeutics for treating melanoma.

Spotlight On: Lindsay Davies, Chief Scientific Officer of NextCell Pharma

We caught up with Lindsay Davies, Chief Scientific Officer of NextCell Pharma, to hear about to hear about the latest advancements in stromal cell therapy in anticipation of her presentation at our Cell & Gene 2024 Congress this November.

Plan Your Visit

Doubletree by Hilton San Diego Mission Valley
7450 Hazard Center Dr, San Diego, CA 92108

By Trolley

The closest Trolley stop to the hotel is Hazard Center Station – this stop is served by the Sycuan Green Line. The hotel is a 7 mins walk from the station. When alighting at this stop, walk north on Hazard Center East Driveway towards Hazard Center Drive. Then turn left and the hotel will be on your right.

By Car

There is self-parking available (garage parking) at the hotel for $34 (this may be subject to state local taxes). There is no valet parking at this venue. For further information please contact the hotel directly. For driving instructions and a map, please click here

By Air

San Diego International Airport – The DoubleTree by Hilton San Diego – Mission Valley is 7 miles from the International Airport. A single taxi ride to the hotel will cost approx. $40 and will take around 20 minutes. Transportation to/from the hotel is provided by Super Shuttle, Cloud 9, or other shuttle services for approx. $10-$15 per person. Please click here for more information on travelling to the hotel from the airport.

By Bus

The closest bus stop to the venue is Camino De La Reina & Mission Center Rd, which is a 13min walk away. When alighting at this stop, walk north on Mission Center Rd towards Camino De La Reina. Turn left onto Hazard Center Dr and then right on to Frazee Rd – the hotel should be on the right hand side. Please click here for more information on Trolley and bus services in the area.

Information regarding accommodation for this event will be added soon

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Cell & Gene US 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch